Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 156 entries
View as:

A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02006628 Org: User:
Start: 02/25/14 End: 01/08/15 Due: 01/08/16

To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04894591 Org: User:
Start: 06/28/21 End: 06/30/25 Due: 06/30/26

A Study of JZP150 in Adults With Posttraumatic Stress Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05178316 Org: User:
Start: 12/29/21 End: 12/05/23 Due: 12/05/24

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Phase: N/A Priority: Normal
NCT ID: NCT02091375 Org: User:
Start: 03/30/15 End: 11/26/15 Due: 11/26/16

Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex

Phase: N/A Priority: Normal
NCT ID: NCT01323465 Org: User:
Start: 02/29/08 End: 03/31/08 Due: 03/31/09

An Open-Label Study of Defibrotide for the Prevention of Acute Graft-versus-Host-Disease (AGvHD)

Phase: N/A Priority: Normal
NCT ID: NCT03339297 Org: User:
Start: 02/21/18 End: 05/12/20 Due: 05/12/21

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Phase: N/A Priority: Normal
NCT ID: NCT02544763 Org: User:
Start: 04/06/16 End: 02/26/19 Due: 02/26/20

A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin

Phase: N/A Priority: Normal
NCT ID: NCT01606176 Org: User:
Start: 03/31/02 End: 08/31/02 Due: 08/31/03

Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT04984278 Org: User:
Start: 08/16/21 End: 11/11/22 Due: 11/11/23

A Study of GWP42006 in People With Focal Seizures - Part B

Phase: N/A Priority: Normal
NCT ID: NCT02365610 Org: User:
Start: 03/31/16 End: 09/30/17 Due: 09/30/18

A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04075747 Org: User:
Start: 12/02/19 End: 09/12/23 Due: 09/12/24

Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT03849456 Org: User:
Start: 01/07/20 End: 05/26/20 Due: 05/26/21

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06282575 Org: User:
Start: 07/19/24 End: 04/01/30 Due: 04/01/31

A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT00713817 Org: User:
Start: 03/31/07 End: 07/31/07 Due: 07/31/08

A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.

Phase: N/A Priority: Normal
NCT ID: NCT00713323 Org: User:
Start: 10/31/05 End: 06/30/07 Due: 06/30/08

Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures

Phase: N/A Priority: Normal
NCT ID: NCT04485104 Org: User:
Start: 05/19/21 End: 01/28/25 Due: 01/28/26

A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05720494 Org: User:
Start: 01/26/23 End: 09/29/23 Due: 09/29/24

A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT01812603 Org: User:
Start: 09/30/13 End: 06/30/16 Due: 06/30/17

Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00901732 Org: User:
Start: 05/31/09 End: 11/30/10 Due: 11/30/11

Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT02806908 Org: User:
Start: 06/30/16 End: 05/19/19 Due: 05/19/20

A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia

Phase: N/A Priority: Normal
NCT ID: NCT00710554 Org: User:
Start: 08/31/05 End: 10/31/06 Due: 10/31/07

Study to Assess Food Effect on Sativex Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT01322464 Org: User:
Start: 01/31/08 End: 02/29/08 Due: 02/28/09

JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase

Phase: N/A Priority: Normal
NCT ID: NCT04943952 Org: User:
Start: - End: - Due: -

Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05126433 Org: User:
Start: 03/03/22 End: 12/20/23 Due: 12/20/24

A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT03436953 Org: User:
Start: 12/31/19 End: 12/31/20 Due: 12/31/21